Showing results (231-240 of 408) with videos related to
Sort By:
Pageof 41
The Journal of Experimental Medicine|November 3, 2010
A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signalingJoanne M Hildebrand, Zhenghua Luo, Michelle K Manske, et al.Blood Neoplasia|July 30, 2025
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408Frederique St-Pierre, Stephen M Broski, Zequn Sun, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.The Lancet. Haematology|May 30, 2020
Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trialGita Thanarajasingam, John P Leonard, Thomas E Witzig, et al.Cancer Cell|June 15, 2013
SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomasLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphomaMyron S Czuczman, Aron Thall, Thomas E Witzig, et al.Blood|July 19, 2011
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemiaMatthew J Maurer, James R Cerhan, Jerry A Katzmann, et al.International Journal of Molecular Epidemiology and Genetics|June 21, 2011
Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphomaJames R Cerhan, Zachary S Fredericksen, Alice H Wang, et al.Pageof 41